Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities

对不起,此内容只适用于EnglishEspañol。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

The Embryotools R&D centre has received support from CDTI (Center for technological and industrial development) to carry out another innovative project with the aim to study new strategies to prevent or reduce the prevalence of chromosomal abnormalities at the early stages of the embryo development.

F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612